AHNAK and ovarian carcinoma: Cai et al. established that AHNAK was downregulated in ovarian cancer and showed that elevated AHNAK expression in ovarian cancer cell lines repressed cell growth and metastasis both in vitro and in vivo notably through the inhibition of the WNT/β-catenin signaling pathway [70].